Secondary hyperparathyroidism in chronic renal failure: Pathogenic and clinical aspects

被引:79
作者
Llach, F
Forero, FV
机构
[1] Georgetown Univ, Med Ctr, Renal Dept, Washington, DC USA
[2] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, DF, Mexico
关键词
secondary hyperparathyroidism; chronic renal failure (CRF); vitamin D;
D O I
10.1053/ajkd.2001.28113
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Secondary hyperparathyroidism occurs early in the course of chronic renal failure. Early in the course, a deficit of calcitriol and an abnormality in the calcium sensor receptor may be the important factors; later, with advanced renal failure, hyperphosphatemia becomes an additional important pathogenic factor. Important clinical problems in dialysis patients are as follows: (1) hyperphosphatemia, which contributes to high morbidity and mortality of dialysis patients (a clinical approach to maintaining a normal serum phosphorus is essential and is discussed in this review); (2) a high calcium X phosphorus product leading to coronary artery calcifications (factors leading to calcifications are also discussed); and (3) calciphylaxis, which has been observed with increasing frequency in these patients (an increase in the total calcium load may be the most important pathogenic factor leading to this syndrome). Therapeutic considerations regarding the use of new vitamin D analogues devoid of a hypercalcemic and/or a hyperphosphatemic effect are also mentioned. (C) 2001 by the National Kidney Foundation, Inc.
引用
收藏
页码:S20 / S33
页数:14
相关论文
共 86 条
[1]  
Acchiardo Sergio, 1999, Journal of the American Society of Nephrology, V10, p615A
[2]  
Almaden Y, 1996, J BONE MINER RES, V11, P970
[3]   A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure -: Rapid communication [J].
Antonsen, JE ;
Sherrard, DJ ;
Andress, DL .
KIDNEY INTERNATIONAL, 1998, 53 (01) :223-227
[4]   MONOCLONALITY OF PARATHYROID TUMORS IN CHRONIC-RENAL-FAILURE AND IN PRIMARY PARATHYROID HYPERPLASIA [J].
ARNOLD, A ;
BROWN, MF ;
URENA, P ;
GAZ, RD ;
SARFATI, E ;
DRUEKE, TB .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2047-2053
[5]   A case control study of proximal calciphylaxis [J].
Bleyer, AJ ;
Choi, M ;
Igwemezie, B ;
de la Torre, E ;
White, WL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (03) :376-383
[6]   Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study [J].
Block, GA ;
Hulbert-Shearon, TE ;
Levin, NW ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :607-617
[7]   Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients [J].
Braun, J ;
Oldendorf, M ;
Moshage, W ;
Heidler, R ;
Zeitler, E ;
Luft, FC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (03) :394-401
[8]   Vitamin D analogues [J].
Brown, AJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (02) :S25-S39
[9]   THE ROLES OF CALCIUM AND 1,25-DIHYDROXYVITAMIN-D3 IN THE REGULATION OF VITAMIN-D-RECEPTOR EXPRESSION BY RAT PARATHYROID-GLANDS [J].
BROWN, AJ ;
ZHONG, M ;
FINCH, J ;
RITTER, C ;
SLATOPOLSKY, E .
ENDOCRINOLOGY, 1995, 136 (04) :1419-1425
[10]   THE NONCALCEMIC ANALOG OF VITAMIN-D, 22-OXACALCITRIOL, SUPPRESSES PARATHYROID-HORMONE SYNTHESIS AND SECRETION [J].
BROWN, AJ ;
RITTER, CR ;
FINCH, JL ;
MORRISSEY, J ;
MARTIN, KJ ;
MURAYAMA, E ;
NISHII, Y ;
SLATOPOLSKY, E .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (03) :728-732